Back to catalog
GLP-1 / Metabolic
Survodutide
4.9 / 5High PurityPharma GradeLab TestedResearch Only
Survodutide (BI 456906) is a dual GLP-1 and glucagon receptor agonist studied for metabolic liver disease and obesity research. Investigations examine MASH histology improvement, glucagon-driven energy expenditure, and weight-loss durability.
For in vitro and laboratory research only. Not for human or veterinary administration. Not evaluated by the FDA.
Variants & Pricing
SUR10
Peptide10mg × 10 vials (kit)
$350
To request this compound, join Discord and open a ticket with the product code and variant.
Order via Discord